Literature DB >> 18358842

Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiation.

Rieko Ajima1, Toru Akiyama, Michihiko Usui, Mitsuhiro Yoneda, Yutaka Yoshida, Takahisa Nakamura, Osamu Minowa, Masaki Noda, Sakae Tanaka, Tetsuo Noda, Tadashi Yamamoto.   

Abstract

Mice lacking tob2, a member of the antiproliferative family genes, had decreased bone mass, and the number of osteoclasts differentiated from bone marrow cells was increased. Overexpression of Tob2 in stromal cells repressed vitamin D(3)-induced osteoclasts formation. Furthermore, expression of RANKL mRNA in stromal cells was increased in the absence of Tob2 and decreased in the presence of Tob2. Tob2 interacted with vitamin D(3) receptor (VDR), which suggests its involvement in vitamin D(3) receptor-mediated regulation of transcription. Because VDR regulates RANKL expression, our data suggest that Tob2 negatively regulates formation of osteoclasts by suppressing RANKL expression through its interaction with VDR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358842     DOI: 10.1016/j.febslet.2008.03.012

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  ANA deficiency enhances bone morphogenetic protein-induced ectopic bone formation via transcriptional events.

Authors:  Kentaro Miyai; Mitsuhiro Yoneda; Urara Hasegawa; Sayaka Toita; Yayoi Izu; Hiroaki Hemmi; Tadayoshi Hayata; Yoichi Ezura; Shuki Mizutani; Kohei Miyazono; Kazunari Akiyoshi; Tadashi Yamamoto; Masaki Noda
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

2.  Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities.

Authors:  Nader Ezzeddine; Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  Mol Cell Biol       Date:  2012-01-17       Impact factor: 4.272

3.  Tob2 inhibits peroxisome proliferator-activated receptor γ2 expression by sequestering Smads and C/EBPα during adipocyte differentiation.

Authors:  Akinori Takahashi; Masahiro Morita; Kazumasa Yokoyama; Toru Suzuki; Tadashi Yamamoto
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

Review 4.  BTG/TOB factors impact deadenylases.

Authors:  Fabienne Mauxion; Chyi-Ying A Chen; Bertrand Séraphin; Ann-Bin Shyu
Journal:  Trends Biochem Sci       Date:  2009-10-12       Impact factor: 13.807

Review 5.  Heterogeneity and complexity within the nuclease module of the Ccr4-Not complex.

Authors:  G Sebastiaan Winkler; Dario L Balacco
Journal:  Front Genet       Date:  2013-12-23       Impact factor: 4.599

6.  Vitamin D receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of juvenile and adolescent idiopathic scoliosis patients.

Authors:  Roman Nowak; Justyna Szota; Urszula Mazurek
Journal:  BMC Musculoskelet Disord       Date:  2012-12-23       Impact factor: 2.362

7.  MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis.

Authors:  Zheng Cao; Benjamin T Moore; Yang Wang; Xian-Hao Peng; Joan M Lappe; Robert R Recker; Peng Xiao
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

8.  Genetic Dissection of Trabecular Bone Structure with Mouse Intersubspecific Consomic Strains.

Authors:  Taro Kataoka; Masaru Tamura; Akiteru Maeno; Shigeharu Wakana; Toshihiko Shiroishi
Journal:  G3 (Bethesda)       Date:  2017-10-05       Impact factor: 3.154

9.  A Novel Regulatory Circuit "C/EBPα/miR-20a-5p/TOB2" Regulates Adipogenesis and Lipogenesis.

Authors:  Jie Zhou; Junying Yang; Xiaochen Wang; Mengyue Li; Fang Li; Endong Zhu; Xuemei Li; Xiaoxia Li; Baoli Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-08       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.